AG002Z9K

29734-68-7 | Dihydro-β-erythroidine (hydrobromide)

Chemical structure of Dihydro-β-erythroidine (hydrobromide), CAS 29734-68-7
AG002Z9K
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 29734-68-7
Catalog Number AG002Z9K(AGN-PC-0R57FD)
Chemical Name Dihydro-β-erythroidine (hydrobromide)
IUPAC Name (1S,16S)-16-methoxy-5-oxa-10-azatetracyclo[8.7.0.01,13.02,7]heptadeca-2(7),13-dien-4-one;hydrobromide
InChI InChI=1S/C16H21NO3.BrH/c1-19-13-3-2-12-5-7-17-6-4-11-10-20-15(18)8-14(11)16(12,17)9-13;/h2,13H,3-10H2,1H3;1H/t13-,16-;/m0./s1
InChI Key GFIGWAJEIMHJJB-LINSIKMZSA-N
MDL Number MFCD00153793
Molecular Formula C16H22BrNO3
Molecular Weight 356.2548
SMILES O([C@H]1CC=C2CCN3CCC4COC(CC=4[C@@]32C1)=O)C.Br
UNII NS1U03GC05
Synonyms
Dihydro-beta-erythroidine hydrobromide, 29734-68-7, UNII-NS1U03GC05, MLS002172468, NS1U03GC05, CHEMBL1319741, (2S,13bS)-2-Methoxy-2,3,5,6,8,9,10,13-octahydro-1H,12H-benzo[i]pyrano[3,4-g]indolizin-12-one hydrobromide, DH?E, EU-0100468, SCHEMBL1320306, Dihydro-?-erythroidine hydrobromide, Tox21_500468, AKOS024457064, LP00468, NCGC00093880-01, NCGC00261153-01, SMR001254098, 3|A-1,6-Didehydro-14,17-dihydro-3-methoxy-16(15H)-oxaerythrinan-15-one hydrobromide, 3beta-1,6-Didehydro-14,17-dihydro-3-methoxy-16(15H)-oxaerythrinan-15-one hydrobromide, 1H,12H-Pyrano[4',3':3,4]pyrido[2,1-i]indol-12-one, 2,3,5,6,8,9,10,13-octahydro-2-methoxy-, hydrobromide (1:1), (2S,13bS)-, C16-H21-N-O3.Br-H, Dihydro-|A-erythroidine hydrobromide, Dihydro-beta-erythroidine hydrogen bromide, CID11957537, beta-ERYTHROIDINE, DIHYDRO-, HYDROBROMIDE, .beta.-Erythroidine, dihydro-, hydrobromide, D-149, .alpha.-Erythroidine, 12,13-didehydro-13,14,?,?-tetrahydro-, hydrobromide,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited